Literature DB >> 30027844

A Walk in Nature: Sesquiterpene Lactones as Multi-Target Agents Involved in Inflammatory Pathways.

Adriana Coricello1, James D Adams2, Eric J Lien2, Christopher Nguyen2, Filomena Perri1, Travis J Williams3, Francesca Aiello1.   

Abstract

Inflammatory states are among the most common and most treated medical conditions. Inflammation comes along with swelling, pain and uneasiness in using the affected area. Inflammation is not always a simple symptom; more often is part of a defensive response of the body to an external threat or is a sign that the damaged tissue has not healed yet and needs to rest. The management of the pain associated with an inflammatory state could be a tricky task. In fact, most remedies simply quench the pain, leaving the inflammatory state unaltered. This review focuses on sesquiterpene lactones, a class of natural compounds, that represents a future promise in the treatment of inflammation. Sesquiterpene lactones are efficient inhibitors of multiple targets of the inflammatory process. Their natural sources are often ancient remedies with relevant traditional uses in folk medicines. This work also aims to elucidate how these compounds may represent the starting material for the development of new anti-inflammatory drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  COX-2; MAPK; NF-κB; Sesquiterpene lactones; anti-inflammatory drugs; inflammation; natural compounds.

Year:  2020        PMID: 30027844     DOI: 10.2174/0929867325666180719111123

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  7 in total

1.  Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.

Authors:  Charles A Berdan; Raymond Ho; Haley S Lehtola; Milton To; Xirui Hu; Tucker R Huffman; Yana Petri; Chad R Altobelli; Sasha G Demeulenaere; James A Olzmann; Thomas J Maimone; Daniel K Nomura
Journal:  Cell Chem Biol       Date:  2019-05-09       Impact factor: 8.116

2.  Costunolide alleviates atherosclerosis in high-fat diet-fed ApoE-/- mice through covalently binding to IKKβ and inhibiting NF-κB-mediated inflammation.

Authors:  Zhu-Qi Huang; Wu Luo; Wei-Xin Li; Pan Chen; Zhe Wang; Rui-Jie Chen; Yi Wang; Wei-Jian Huang; Guang Liang
Journal:  Acta Pharmacol Sin       Date:  2022-06-16       Impact factor: 6.150

Review 3.  Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates.

Authors:  Adriana Coricello; Francesco Mesiti; Antonio Lupia; Annalisa Maruca; Stefano Alcaro
Journal:  Molecules       Date:  2020-07-22       Impact factor: 4.411

Review 4.  Anti-Inflammatory and Immunoregulatory Action of Sesquiterpene Lactones.

Authors:  Ana Paço; Teresa Brás; Jacqueline O Santos; Paula Sampaio; Andreia C Gomes; Maria F Duarte
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

5.  Archangelolide: A sesquiterpene lactone with immunobiological potential from Laserpitium archangelica.

Authors:  Silvie Rimpelová; Michal Jurášek; Lucie Peterková; Jiří Bejček; Vojtěch Spiwok; Miloš Majdl; Michal Jirásko; Miloš Buděšínský; Juraj Harmatha; Eva Kmoníčková; Pavel Drašar; Tomáš Ruml
Journal:  Beilstein J Org Chem       Date:  2019-08-13       Impact factor: 2.883

6.  Design, Synthesis and In Vitro Experimental Validation of Novel TRPV4 Antagonists Inspired by Labdane Diterpenes.

Authors:  Sarah Mazzotta; Gabriele Carullo; Aniello Schiano Moriello; Pietro Amodeo; Vincenzo Di Marzo; Margarita Vega-Holm; Rosa Maria Vitale; Francesca Aiello; Antonella Brizzi; Luciano De Petrocellis
Journal:  Mar Drugs       Date:  2020-10-18       Impact factor: 5.118

7.  Synthesis, Crystallography, and Anti-Leukemic Activity of the Amino Adducts of Dehydroleucodine.

Authors:  Paola E Ordóñez; David E Mery; Krishan K Sharma; Saumyadip Nemu; William F Reynolds; Raul G Enriquez; Darcy C Burns; Omar Malagón; Darin E Jones; Monica L Guzman; Cesar M Compadre
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.